NeuroSense Therapeutics

Home
United States
Cambridge, MA
NeuroSense Therapeutics

Biotech company, developing drug for ALS patients
Nasdaq: NRSN

Contact us at: [email protected]

NeuroSense was born with the intent to answer the huge unmet need of patients with amyotrophic lateral sclerosis (ALS) with the understanding that this devastating disease must be addressed from a new perspective. NeuroSense Therapeutics is a clinical-stage drug development company, advancing a groundbreaking treatment for people living with ALS, as well as other neurodegenerative diseases. We are

focused on creating combined therapeutic strategies, targeting the multiple pertinent mechanisms in these complex diseases.

Address

Cambridge, MA
02142

Website

http://www.neurosense-tx.com/

Alerts

Be the first to know and let us send you an email when NeuroSense Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.